Effect of TACE combined with radiofrequency ablation on survival in patients with recurrent liver cancer
Objective To explore the effect of transcatheter arterial chemoembolization(TACE)and radiofrequency ablation(RFA)on the survival in patients with recurrent liver cancer.Methods 80 patients with recurrent liver cancer admitted to our hospital from May 2018 to May 2021 were selected as the research subjects.All patients were pathologically diagnosed with liver cancer and had relapsed after at least one surgical treatment.According to the different treatment methods,the patients were divided into two groups:control group and observation group.35 patients in the control group were treated with RFA alone,while 45 patients in the observation group were treated with TACE combined with RFA.The tumor-free survival rate,overall survival rate and complication rates of the two groups within 3 years after surgery were compared and analyzed.Results There was no significant difference between the observation group and the control group in terms of tumor-free survival and overall survival within 1 year after surgery.The tumor-free survival rate and overall survival rate of patients in the observation group were significantly higher than those in the control group within 2 and 3 years after surgery(P<0.05).The results of multivariate logistic multiple regression analysis showed that the short time from recurrence to surgery and TACE combined with RFA therapy were important factors affecting the overall survival rate of patients with recurrent liver cancer within 3 years.Conclusion TACE combined with RFA therapy has a significant impact on the survival of patients with recurrent liver cancer,and this method can improve the tumor-free survival rate and overall survival rate of patients,which is worthy of further promotion and appli-cation in clinical practice.
万方数据
维普
